Propel Bio Management, LLC Applied Therapeutics Inc. Transaction History
Propel Bio Management, LLC
- $101 Billion
- Q4 2024
A detailed history of Propel Bio Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 9,615,420 shares of APLT stock, worth $5.1 Million. This represents 8.18% of its overall portfolio holdings.
Number of Shares
9,615,420
Previous 6,567,858
46.4%
Holding current value
$5.1 Million
Previous $55.8 Billion
85.25%
% of portfolio
8.18%
Previous 32.38%
Shares
4 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$6.1 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$5.3 Million1.4% of portfolio
-
Morgan Stanley New York, NY8.82MShares$4.67 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$4.64 Million0.05% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$3.48 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $25.5M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...